CN Stock MarketDetailed Quotes
688739 Liaoning Chengda Biotechnology
- 27.34
- -0.70-2.50%
Market Closed Dec 13 15:00 CST
11.39BMarket Cap34.30P/E (TTM)
27.98High27.28Low40.10KlotVolume27.98Open28.04Pre Close110.27MTurnover2.12%Turnover Ratio24.43P/E (Static)416.45MShares33.1552wk High1.19P/B5.16BFloat Cap21.9552wk Low33.65Limit Up188.79MShs Float87.20Historical High22.43Limit Down2.50%Amplitude21.95Historical Low0.80Dividend TTM27.50Avg Price26.22KlotAsk2.93%Div YieldTTM100Lot Size12.86KlotBid
Liaoning Chengda Biotechnology Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -2.40%1.3B | 1.08%880.69M | 3.16%364.71M | -3.58%1.75B | -1.88%1.33B | -1.13%871.31M | -3.50%353.52M | -13.08%1.81B | -21.60%1.36B | -24.83%881.3M |
| Operating revenue | -2.40%1.3B | 1.08%880.69M | 3.16%364.71M | -3.58%1.75B | -1.88%1.33B | -1.13%871.31M | -3.50%353.52M | -13.08%1.81B | -21.60%1.36B | -24.83%881.3M |
| Total operating cost | 14.07%872.11M | 23.55%585.94M | 21.37%257.81M | 10.71%1.1B | 6.37%764.51M | 2.72%474.26M | 5.39%212.42M | -6.94%997.16M | -4.46%718.73M | -9.90%461.7M |
| Operating cost | 13.24%222.55M | 16.47%151.29M | 13.38%62.38M | 22.34%286.15M | 27.52%196.53M | 36.69%129.89M | 44.58%55.02M | 10.37%233.89M | -11.94%154.12M | -23.87%95.02M |
| Operating tax surcharges | 3.04%16.95M | 6.92%11.35M | 9.82%5.32M | -1.11%21.86M | -1.77%16.45M | -5.24%10.62M | -16.34%4.85M | 6.18%22.1M | 2.01%16.74M | 9.95%11.2M |
| Operating expense | 1.81%299.22M | 10.02%191.14M | 12.91%86.1M | 7.83%397.51M | 9.86%293.89M | 5.75%173.74M | 0.85%76.26M | -4.05%368.65M | 7.19%267.52M | -2.04%164.29M |
| Administration expense | -5.60%166.31M | 0.17%109.95M | 17.71%59.66M | 14.18%250.28M | 14.50%176.17M | 18.02%109.76M | 19.16%50.69M | -0.59%219.19M | 9.30%153.86M | -4.90%93M |
| Financial expense | 30.48%-40.19M | 33.05%-27.22M | 21.95%-14.65M | -24.43%-72.34M | -60.38%-57.82M | -142.87%-40.66M | -142.56%-18.77M | -1,499.74%-58.14M | -3,442.60%-36.05M | -9,953.48%-16.74M |
| -Interest expense (Financial expense) | -14.23%643.98K | -13.12%442.94K | -13.18%225.27K | 7.57%1.42M | -14.90%750.79K | -15.20%509.82K | -14.91%259.46K | -14.28%1.32M | -22.29%882.21K | -25.25%601.2K |
| -Interest Income (Financial expense) | 28.14%-41.02M | 31.10%-27.28M | 24.07%-14.97M | -25.03%-71.79M | -66.05%-57.07M | -136.07%-39.59M | -140.60%-19.71M | -845.28%-57.42M | -1,121.36%-34.37M | -971.57%-16.77M |
| Research and development | 48.81%207.28M | 64.37%149.43M | 32.94%59M | 4.26%220.46M | -14.31%139.29M | -20.90%90.91M | -6.17%44.38M | -11.05%211.46M | -5.23%162.54M | 2.53%114.92M |
| Credit Impairment Loss | 21.46%-11.14M | 5.50%-9.89M | -103.17%-1.46M | 13.26%-13.09M | -20.57%-14.18M | 29.25%-10.47M | 83.78%-717.53K | 8.19%-15.09M | 46.96%-11.76M | 10.75%-14.8M |
| Asset Impairment Loss | 41.42%-26.46M | -43.88%-20.06M | -190.80%-10.71M | -1,069.63%-109.81M | -1,342.65%-45.16M | -345.47%-13.94M | -156.47%-3.68M | -46.44%-9.39M | -82.09%-3.13M | -80.27%-3.13M |
| Other net revenue | ||||||||||
| Fair value change income | -396.55%-15.94M | -309.09%-10.94M | -22.10%4.55M | 118.57%8.1M | 246.54%5.37M | 195.92%5.23M | 1,846.63%5.84M | -70.91%-43.63M | 90.85%-3.67M | 31.52%-5.45M |
| Invest income | -34.75%14.61M | -36.75%8.23M | -17.24%2.82M | -64.70%25.02M | -63.41%22.39M | -75.04%13.01M | -79.69%3.41M | 78.40%70.89M | 166.30%61.2M | 246.95%52.11M |
| -Including: Investment income associates | -1,136.85%-6.37M | -1,561.00%-2.05M | -182.68%-1.28M | 35.33%-7.21M | 112.66%614.76K | 105.30%140.35K | 216.93%1.55M | ---11.15M | ---4.86M | ---2.65M |
| Asset deal income | 170.20%90.85K | 931.07%90.85K | --43.07K | 5,698.52%2.48M | 1,229.69%33.62K | 124.47%8.81K | ---- | 205.55%42.81K | -81.95%2.53K | -357.00%-36.01K |
| Other revenue | 4.56%15.24M | 15.05%11.54M | 21.38%5.88M | 1.02%18.9M | 42.58%14.58M | 65.88%10.03M | 62.19%4.85M | 26.23%18.71M | -1.86%10.22M | -9.89%6.05M |
| Operating profit | -26.43%406.99M | -31.73%273.72M | -28.37%108.02M | -31.16%577.8M | -20.33%553.21M | -11.76%400.92M | -15.75%150.8M | -17.93%839.37M | -27.07%694.37M | -30.68%454.35M |
| Add:Non operating Income | 106.85%111.7K | 119.40%109.7K | --1K | 25.83%1.54M | 100.00%54K | 150.00%50K | ---- | -92.15%1.22M | -99.70%27K | -99.78%20K |
| Less:Non operating expense | 59.60%1.94M | 250.81%1.68M | -58.15%55.82K | 17.37%2.96M | 45.13%1.21M | 16.61%477.97K | -56.67%133.38K | -65.53%2.52M | -76.64%836.42K | -5.18%409.88K |
| Total profit | -26.61%405.16M | -32.04%272.15M | -28.34%107.97M | -31.23%576.38M | -20.40%552.05M | -11.78%400.49M | -15.69%150.66M | -18.71%838.07M | -27.58%693.57M | -31.65%453.96M |
| Less:Income tax cost | -14.77%75.46M | -22.34%51.94M | 12.21%26.5M | -10.96%110.46M | -15.20%88.54M | -8.25%66.88M | -14.98%23.62M | -10.42%124.05M | -19.08%104.41M | -17.77%72.89M |
| Net profit | -28.87%329.7M | -33.99%220.21M | -35.88%81.46M | -34.75%465.92M | -21.33%463.52M | -12.45%333.61M | -15.82%127.04M | -20.00%714.02M | -28.90%589.16M | -33.78%381.07M |
| Net profit from continuing operation | -28.87%329.7M | -33.99%220.21M | -35.88%81.46M | -34.75%465.92M | -21.33%463.52M | -12.45%333.61M | -15.82%127.04M | -20.00%714.02M | -28.90%589.16M | -33.78%381.07M |
| Net profit of parent company owners | -28.87%329.7M | -33.99%220.21M | -35.88%81.46M | -34.75%465.92M | -21.33%463.52M | -12.45%333.61M | -15.82%127.04M | -20.00%714.02M | -28.90%589.16M | -33.78%381.07M |
| Earning per share | ||||||||||
| Basic earning per share | -27.93%0.8 | -33.75%0.53 | -35.48%0.2 | -34.50%1.12 | -21.28%1.11 | -13.04%0.8 | -13.89%0.31 | -26.92%1.71 | -36.20%1.41 | -40.26%0.92 |
| Diluted earning per share | -27.93%0.8 | -33.75%0.53 | -35.48%0.2 | -34.50%1.12 | -21.28%1.11 | -13.04%0.8 | -13.89%0.31 | -26.92%1.71 | -36.20%1.41 | -40.26%0.92 |
| Other composite income | ||||||||||
| Total composite income | -28.87%329.7M | -33.99%220.21M | -35.88%81.46M | -34.75%465.92M | -21.33%463.52M | -12.45%333.61M | -15.82%127.04M | -20.00%714.02M | -28.90%589.16M | -33.78%381.07M |
| Total composite income of parent company owners | -28.87%329.7M | -33.99%220.21M | -35.88%81.46M | -34.75%465.92M | -21.33%463.52M | -12.45%333.61M | -15.82%127.04M | -20.00%714.02M | -28.90%589.16M | -33.78%381.07M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
